title: The antilipemic effectiveness of aluminium clofibrate on hyperlipidemic patients with or without diabetes mellitus.
authors.forename: H C
authors.initials: HC
authors.lastname: Lam
authors.forename: S H
authors.initials: SH
authors.lastname: Li
authors.forename: J T
authors.initials: JT
authors.lastname: Wang
authors.forename: K T
authors.initials: KT
authors.lastname: Tang
authors.forename: L T
authors.initials: LT
authors.lastname: Ho
mesh_terms: D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000031:analogs & derivatives*; D002995:Clofibric Acid / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D048909:Diabetes Complications; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged
chemical_list: D000960:Hypolipidemic Agents; C005681:alfibrate; D002995:Clofibric Acid; D002994:Clofibrate